Jose Cardona
General Practice · Miami, FLNPI 1932107695
Payments from drug & device makers
Across 3,050 payments — averaging $23,279 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$21.7M
- Pfizer$20.1M
- Merck$6.3M
- Eli Lilly$3.6M
- AstraZeneca$2.9M
- Janssen Research & Development, LLC$2.2M
- plus $14.1M from 32 others
Across 45 payments — averaging $3321.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$124K
- Pfizer$21K
- Sanofi Pasteur Inc.$2K
- Radius Health, Inc.$2K
- AbbVie$825
- Otsuka Pharmaceutical Development & Commercialization, Inc.$273
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$71,001,492 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.
Other general practice in Miami
- Armando AcevedoMiami$15.2M
- Jorge AmayaMiami$14.2M
- Hector RodriguezMiami$12.8M
- Idalia AcostaMiami$11.4M
- Lilia Rodriguez AblesMiami$10.7M
- Omar BenitezMiami$6.9M
- Sara LlerenaMiami$6.3M
- Ana AcostaMiami$6.3M
- Gil Fernandez-YeraMiami$4.9M
- Manuel FernandezMiami$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.